Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07921719

PROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program

Sponsor: Hospices Civils de Lyon

View on ClinicalTrials.gov

Summary

This prospective observational study aims to evaluate whether an intensive tele-tobacco cessation program delivered through the PROMETHEE platform improves smoking cessation among smokers participating in the French national lung cancer screening pilot program IMPULSION. Participants receiving the PROMETHEE pathway will be compared with matched controls receiving standard smoking cessation support available through IMPULSION. The primary endpoint is self-reported smoking cessation at 12 months.

Official title: Evaluation of an Intensive Tele-Tobacco Cessation Program Compared With Standard Smoking Cessation Support in Participants of the French IMPULSION Lung Cancer Screening Program (PROMETHEE)

Key Details

Gender

All

Age Range

50 Years - 74 Years

Study Type

OBSERVATIONAL

Enrollment

5400

Start Date

2027-01

Completion Date

2030-01

Last Updated

2026-11-06

Healthy Volunteers

Not specified

Interventions

OTHER

PROMETHEE Cohort

PROMETHEE tele-tobacco platform

OTHER

Control Cohort

Routine IMPULSION Cohorte

Locations (1)

Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique, Hôpital Lyon Sud, Hospices Civils de Lyon

Pierre-Bénite, France